For less urgent concerns, contact your GP or call NHS 111 for advice
Some regulators are cautious, but many physicians remain unconvinced
10,11 California's spending on the three drugs approved for the weight loss indication increased fourfold from early 2024 to mid 2025, as outlined in Figure 2
muciniphila and metabolic phenotypes: OGTT AUC (oral glucose tolerance test area under the curve), iBAT temp (interscapular brown adipose tissue temperature), and GLP-1 (plasma glucagon-like peptide-1 concentration)
However, its important to understand that IV therapy may not be suitable for everyone
A strong GLP-1 program should include proper screening, individualized dosing, follow-up, muscle-preservation guidance, side-effect management, and realistic maintenance planning